These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21584903)

  • 1. Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.
    Chen Z; Liu Z; Li W; Qu K; Deng X; Varma MG; Fichera A; Pigazzi A; Garcia-Aguilar J
    Genes Chromosomes Cancer; 2011 Sep; 50(9):689-99. PubMed ID: 21584903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer.
    Chen Z; Liu Z; Deng X; Warden C; Li W; Garcia-Aguilar J
    Dis Colon Rectum; 2012 Jun; 55(6):677-85. PubMed ID: 22595848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic changes in rectal adenocarcinoma associated with liver metastasis.
    Zhou HT; Shi ZZ; Zhou ZX; Jiang YY; Hao JJ; Zhang TT; Shi F; Xu X; Wang MR; Zhang Y
    Cancer Biomark; 2013; 13(4):281-8. PubMed ID: 24240589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of rectal adenoma and carcinoma by array-based comparative genomic hybridization.
    Shi ZZ; Zhang YM; Shang L; Hao JJ; Zhang TT; Wang BS; Liang JW; Chen X; Zhang Y; Wang GQ; Wang MR; Zhang Y
    BMC Med Genomics; 2012 Nov; 5():52. PubMed ID: 23158542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type.
    Jin DH; Park SE; Lee J; Kim KM; Kim S; Kim DH; Park J
    PLoS One; 2015; 10(9):e0137657. PubMed ID: 26360582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
    Lee TH; Jang BS; Chang JH; Kim E; Park JH; Chie EK
    Cancer Med; 2023 Jul; 12(14):15664-15675. PubMed ID: 37260182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.
    Molinari C; Ballardini M; Teodorani N; Giannini M; Zoli W; Emiliani E; Lucci E; Passardi A; Rosetti P; Saragoni L; Guidoboni M; Amadori D; Calistri D
    Radiat Oncol; 2011 Nov; 6():161. PubMed ID: 22099067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genomic aberrations associated with the clinicopathological parameters of rectal cancer by array‑based comparative genomic hybridization.
    Liang JW; Shi ZZ; Zhang TT; Hao JJ; Wang Z; Wang XM; Yang H; Wang MR; Zhou ZX; Zhang Y
    Oncol Rep; 2013 May; 29(5):1827-34. PubMed ID: 23440507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile is associated with chemoradiation resistance in rectal cancer.
    Gantt GA; Chen Y; Dejulius K; Mace AG; Barnholtz-Sloan J; Kalady MF
    Colorectal Dis; 2014 Jan; 16(1):57-66. PubMed ID: 24034224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.
    Sorenson E; Lambreton F; Yu JQ; Li T; Denlinger CS; Meyer JE; Sigurdson ER; Farma JM
    J Surg Res; 2019 Nov; 243():242-248. PubMed ID: 31229791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
    Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
    Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic response following treatment for locally advanced rectal cancer: Does location matter?
    Ward WH; Sigurdson ER; Esposito AC; Ruth KJ; Manstein SM; Sorenson EC; Wernick BD; Farma JM
    J Surg Res; 2018 Apr; 224():215-221. PubMed ID: 29506843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer.
    Li N; Dou L; Zhang Y; Jin J; Wang G; Xiao Q; Li Y; Wang X; Ren H; Fang H; Wang W; Wang S; Liu Y; Song Y
    Gastrointest Endosc; 2017 Mar; 85(3):669-674. PubMed ID: 27354104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
    Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
    Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.
    Grade M; Gaedcke J; Wangsa D; Varma S; Beckmann J; Liersch T; Hess C; Becker H; Difilippantonio MJ; Ried T; Ghadimi BM
    Cancer Genet Cytogenet; 2009 Aug; 193(1):19-28. PubMed ID: 19602460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.